Jeffrey B Fleigenspan Md Fort Lauderdale, FL - 33326

Jeffrey B Fleigenspan Md is categorized under Physicians Offices in Fort Lauderdale, FL and active since 1994.

Jeffrey B Fleigenspan Md was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Dr Jeffrey B Fleigenspan at the company’s single location by writing to 1625 North Commerce Parkway, Fort Lauderdale, Florida FL 33326 or by phoning (954) 389-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Jeffrey B Fleigenspan Md
Contact Person: Dr Jeffrey B Fleigenspan
Address: 1625 North Commerce Parkway, Fort Lauderdale, Florida 33326
Phone Number: (954) 389-7000
Annual Revenue (USD): $100.000 to $499.999
Founded: 1994
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Jeffrey B Fleigenspan Md was started in 1994 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Dr Jeffrey B Fleigenspan for inquiries that concern Jeffrey B Fleigenspan Md by calling the company number (954) 389-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Jeffrey B Fleigenspan Md can be found at the coordinates 26.098938,-80.366755 as well as the street address 1625 North Commerce Parkway in Fort Lauderdale, Florida 33326.

For its online presence, you may visit Jeffrey B Fleigenspan Md’s website at and engage with its social media outlets through on Twitter and on Facebook.